Company / Total Assets
SAB Biotherapeutics, Inc. Total Assets History
FY2021-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Total Assets
$172.8M
FY2025
5-year range
$44.2M / $172.8M
FY2021-FY2025
Trend
+291.0%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Total Assets changed +291% YoY in FY2025, a notable deviation from the 4-year average annual change of +73%.
Based on SEC 10-K filings.
$173M in FY2025 with a 3-year CAGR of +28.7%.
Improved from $84M to $173M over the past 2 years.
Total Assets over time
Growth rates
- 3-Year CAGR
- +28.7%
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- 3-year CAGR of +28.7%, indicating consistent growth.
- In FY2025, total assets increased 291.0% year-over-year.
- Lowest total assets in the period was in FY2024.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -0.31 (distress zone, below 1.8 threshold)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Total AssetsValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $172.8M | +291.0% |
| FY2024 | $44.2M | -47.3% |
| FY2023 | $83.9M | +3.5% |
| FY2022 | $81.1M | +43.5% |
| FY2021 | $56.5M | - |
As of FY2025 · SEC 10-K · Updated Jun 28, 2026